Calliditas: First patient enrolled in Phase III
Research Note
2018-11-13
17:01
The first patient has been enrolled in the Phase III NEFIGARD study, putting the company on-track to reach its goal of top-line readout in H2-2020.
MS
Mathias Spinnars
Disclosures and disclaimers